Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia. (2023)

First Author: Barber VS
Attributed to:  COVID-19 Immunity - National Core Study (IMM-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2023-077946

PubMed Identifier: 37770269

Publication URI: http://europepmc.org/abstract/MED/37770269

Type: Journal Article/Review

Volume: 13

Parent Publication: BMJ open

Issue: 9

ISSN: 2044-6055